Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Korea/Asia, Events, IPOs

Event-Driven

<ul>
<li>We discuss the end of the mandatory lock-up periods for 49 stocks in Korea in September 2023, among which 7 are in KOSPI and 42 are in KOSDAQ.</li>
<li>These 49 stocks on average could be subject to further selling pressures in September and could underperform relative to the market. </li>
<li>Among these 49 stocks, top five market cap stocks include <a href="https://www.smartkarma.com/entities/kakao-games-corp" target="_blank" data-smartkarma-citation="entities:26730:1" rel="noopener">Kakao Games (293490 KS)</a>, <a href="https://www.smartkarma.com/entities/sk-oceanplant-co-ltd" target="_blank" data-smartkarma-citation="entities:7263:1" rel="noopener">SK Oceanplant (100090 KS)</a>, <a href="https://www.smartkarma.com/entities/korea-zinc-co-ltd" target="_blank" data-smartkarma-citation="entities:17944:1" rel="noopener">Korea Zinc (010130 KS)</a>, <a href="https://www.smartkarma.com/entities/fadu-inc" target="_blank" data-smartkarma-citation="entities:39896:1" rel="noopener">Fadu (440110 KS)</a>, and <a href="https://www.smartkarma.com/entities/vaxcell-bio-therapeutics-co-ltd" target="_blank" data-smartkarma-citation="entities:35613:1" rel="noopener">Vaxcell-Bio Therapeutics (323990 KS)</a>. </li>
</ul>


We discuss the end of the mandatory lock-up periods for 49 stocks in Korea in September 2023, among which 7 are in KOSPI and 42 are in KOSDAQ.
These 49 stocks on average could be subject to further selling pressures in September and could underperform relative to the market. 
Among these 49 stocks, top five market cap stocks include Kakao Games (293490 KS), SK Oceanplant (100090 KS), Korea Zinc (010130 KS), Fadu (440110 KS), and Vaxcell-Bio Therapeutics (323990 KS). 


End of Mandatory Lock-Up Periods for 49 Companies in Korea in September 2023

South Korea

Vaxcell-Bio Therapeutics, Co. Ltd operates pharmaceutical development businesses. The Company develops anti-cancer drugs, cellular drugs, immune drugs, and other medicines. Vaxcell-Bio Therapeutics conducts businesses in South Korea.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00